A number of key waivers put in place at the beginning of the COVID-19 Public Health Emergency to facilitate widespread testing will end when the emergency declaration expires on May 11, according to recent updates from CMS. While labs and providers performing COVID...
A couple of key laboratory legislative issues that were put on hold at the end of 2022 now appear to be making comebacks as they seek new Congressional champions. Check out the news roundup below for the latest developments on VALID, SALSA, and more. VALID...
While the future of healthcare may be value-based, the reality is most laboratories and pathologists still largely operate in a fee-for-service environment. Given that fact, understanding how to effectively track and negotiate your insurance payer contracts is a must...
By: Dyana Williams, Client Manager, LLS RCM Solutions One of the less familiar provisions in the No Surprises Act is a requirement for in-network health plan provider directories to be maintained and verified no less than every 90 days. These rules apply to providers,...
Clinical laboratories and healthcare providers as a whole received a number of welcome reprieves from potential payment cuts and burdensome regulation as 2022 drew to a close. But that doesn’t mean many of these issues couldn’t be resurrected in a different form in...
In a win for laboratory innovation, the VALID Act, which would have created a new risk-based framework for regulating lab developed tests (LDTs), was excluded from the year-end omnibus spending package recently finalized by Congress, meaning the legislation...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy